N-methyl-D-aspartate Receptor Activation Mediates Lung Fibroblast Proliferation and Differentiation in Hyperoxia-induced Chronic Lung Disease in Newborn Rats

Overview

Journal Respir Res

Specialty Pulmonary Medicine

Date 2016 Oct 23

PMID 27769245

Citations 9

Authors

Yanrui Wang

Shaojie Yue

Ziqiang Luo

Chuanding Cao

Xiaohe Yu

Zhengchang Liao

Mingjie Wang

Affiliations

Soon will be listed here.

Abstract

Background: Previous studies have suggested that endogenous glutamate and its N-methyl-D-aspartate receptors (NMDARs) play important roles in hyperoxia-induced acute lung injury in newborn rats. We hypothesized that NMDAR activation also participates in the development of chronic lung injury after withdrawal of hyperoxic conditions.

Methods: In order to rule out the anti-inflammatory effects of NMDAR inhibitor on acute lung injury, the efficacy of MK-801 was evaluated in vivo using newborn Sprague-Dawley rats treated starting 4 days after cessation of hyperoxia exposure (on postnatal day 8). The role of NMDAR activation in hyperoxia-induced lung fibroblast proliferation and differentiation was examined in vitro using primary cells derived from the lungs of 8-day-old Sprague-Dawley rats exposed to hyperoxic conditions.

Results: Hyperoxia for 3 days induced acute lung injury in newborn rats. The acute injury almost completely disappeared 4 days after cessation of hyperoxia exposure. However, pulmonary fibrosis, impaired alveolarization, and decreased pulmonary compliance were observed on postnatal days 15 and 22. MK-801 treatment during the recovery period was found to alleviate the chronic damage induced by hyperoxia. Four NMDAR 2 s were found to be upregulated in the lung fibroblasts of newborn rats exposed to hyperoxia. In addition, the proliferation and upregulation of alpha-smooth muscle actin and (pro) collagen I in lung fibroblasts were detected in hyperoxia-exposed rats. MK-801 inhibited these changes.

Conclusions: NMDAR activation mediated lung fibroblast proliferation and differentiation and played a role in the development of hyperoxia-induced chronic lung damage in newborn rats.

Citing Articles

NMDAR activation attenuates the protective effect of BM-MSCs on bleomycin-induced ALI via the COX-2/PGE pathway.

Li X, Huang P, Cheng H, Zhou Y, Feng D, Yue S Heliyon. 2024; 10(1):e23723.

PMID: 38205313 PMC: 10776937. DOI: 10.1016/j.heliyon.2023.e23723.

NMDA receptor modulation and severe acute respiratory syndrome treatment.

Costa B F1000Res. 2022; 10.

PMID: 36544563 PMC: 9745209. DOI: 10.12688/f1000research.73897.1.

Intratracheal administration of umbilical cord-derived mesenchymal stem cells attenuates hyperoxia-induced multi-organ injury heme oxygenase-1 and JAK/STAT pathways.

Dong N, Zhou P, Li D, Zhu H, Liu L, Ma H World J Stem Cells. 2022; 14(7):556-576.

PMID: 36157523 PMC: 9350625. DOI: 10.4252/wjsc.v14.i7.556.

N-methyl-D-aspartate receptor blockers attenuate bleomycin-induced pulmonary fibrosis by inhibiting endogenous mesenchymal stem cells senescence.

Huang P, Zhou Y, Li X, Zhang Y, Cheng H, Fu J Ann Transl Med. 2022; 10(11):642.

PMID: 35813315 PMC: 9263776. DOI: 10.21037/atm-22-2507.

Effects of Anesthesia on Ozone-Induced Lung and Systemic Inflammation.

Wilson M, Thysell J, Baumann K, Quaranta D, Liang W, Erickson M Lung. 2022; 200(2):269-275.

PMID: 35199228 PMC: 9038869. DOI: 10.1007/s00408-022-00514-5.

References

Tang F, Yue S, Luo Z, Feng D, Wang M, Qian C . Role of N-methyl-D-aspartate receptor in hyperoxia-induced lung injury. Pediatr Pulmonol. 2005; 40(5):437-44. DOI: 10.1002/ppul.20299. View

Roberts Jr J, Roberts C, Jones R, Zapol W, Bloch K . Continuous nitric oxide inhalation reduces pulmonary arterial structural changes, right ventricular hypertrophy, and growth retardation in the hypoxic newborn rat. Circ Res. 1995; 76(2):215-22. DOI: 10.1161/01.res.76.2.215. View

Baum B, Moss J, Breul S, Crystal R . Association in normal human fibroblasts of elevated levels of adenosine 3':5'-monophosphate with a selective decrease in collagen production. J Biol Chem. 1978; 253(10):3391-4. View

Stahl W, WARD C, Casper J, Bird T . Effects of L-glutamate on viabilities of cultured diploid skin fibroblasts and lymphocytes. Increased toxicity not observed in Huntington's disease. J Neurol Sci. 1984; 66(2-3):183-91. DOI: 10.1016/0022-510x(84)90006-6. View

Fries K, Blieden T, Looney R, Sempowski G, Silvera M, WILLIS R . Evidence of fibroblast heterogeneity and the role of fibroblast subpopulations in fibrosis. Clin Immunol Immunopathol. 1994; 72(3):283-92. DOI: 10.1006/clin.1994.1144. View

Bullock R, Zauner A, Myseros J, Marmarou A, Woodward J, Young H . Evidence for prolonged release of excitatory amino acids in severe human head trauma. Relationship to clinical events. Ann N Y Acad Sci. 1995; 765:290-7; discussion 298. DOI: 10.1111/j.1749-6632.1995.tb16586.x. View

Archer F, MANCALL E . Cultured fibroblasts in Huntington's disease. I. Effects of L-glutamic acid. Arch Neurol. 1983; 40(1):19-23. DOI: 10.1001/archneur.1983.04050010039009. View

Cooney T, Thurlbeck W . The radial alveolar count method of Emery and Mithal: a reappraisal 2--intrauterine and early postnatal lung growth. Thorax. 1982; 37(8):580-3. PMC: 459378. DOI: 10.1136/thx.37.8.580. View

Cooney T, Thurlbeck W . The radial alveolar count method of Emery and Mithal: a reappraisal 1--postnatal lung growth. Thorax. 1982; 37(8):572-9. PMC: 459377. DOI: 10.1136/thx.37.8.572. View

10.

Hansmann G, Fernandez-Gonzalez A, Aslam M, Vitali S, Martin T, Mitsialis S . Mesenchymal stem cell-mediated reversal of bronchopulmonary dysplasia and associated pulmonary hypertension. Pulm Circ. 2012; 2(2):170-81. PMC: 3401871. DOI: 10.4103/2045-8932.97603. View

11.

Luk K, Sadikot A . Glutamate and regulation of proliferation in the developing mammalian telencephalon. Dev Neurosci. 2005; 26(2-4):218-28. DOI: 10.1159/000082139. View

12.

Sun H, Choo-Wing R, Fan J, Leng L, Syed M, Hare A . Small molecular modulation of macrophage migration inhibitory factor in the hyperoxia-induced mouse model of bronchopulmonary dysplasia. Respir Res. 2013; 14:27. PMC: 3637059. DOI: 10.1186/1465-9921-14-27. View

13.

Zorumski C, Olney J . Excitotoxic neuronal damage and neuropsychiatric disorders. Pharmacol Ther. 1993; 59(2):145-62. DOI: 10.1016/0163-7258(93)90043-d. View

14.

Rehan V, Wang Y, Patel S, Santos J, Torday J . Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, prevents hyperoxia-induced neonatal rat lung injury in vivo. Pediatr Pulmonol. 2006; 41(6):558-69. DOI: 10.1002/ppul.20407. View

15.

Mayer M, Westbrook G . The physiology of excitatory amino acids in the vertebrate central nervous system. Prog Neurobiol. 1987; 28(3):197-276. DOI: 10.1016/0301-0082(87)90011-6. View

16.

Gray P, May P, Mundy L, Elkins J . L-Glutamate toxicity in Huntington's disease fibroblasts. Biochem Biophys Res Commun. 1980; 95(2):707-14. DOI: 10.1016/0006-291x(80)90843-8. View

17.

Mori H, Mishina M . Structure and function of the NMDA receptor channel. Neuropharmacology. 1995; 34(10):1219-37. DOI: 10.1016/0028-3908(95)00109-j. View

18.

Said S, Pakbaz H, Berisha H, Raza S . NMDA receptor activation: critical role in oxidant tissue injury. Free Radic Biol Med. 2000; 28(8):1300-2. DOI: 10.1016/s0891-5849(00)00289-6. View

19.

. Dexamethasone therapy in neonatal chronic lung disease: an international placebo-controlled trial. Collaborative Dexamethasone Trial Group. Pediatrics. 1991; 88(3):421-7. View

20.

Obrenovitch T, Urenjak J . Is high extracellular glutamate the key to excitotoxicity in traumatic brain injury?. J Neurotrauma. 1997; 14(10):677-98. DOI: 10.1089/neu.1997.14.677. View